Public Company News

TDK and Gelion Establish Full Collaboration Agreement

To advance Sulfur battery technology anticipated to be transformational for the industry SYDNEY, Oct. 21, 2025 /PRNewswire/ -- Gelion plc (AIM: GELN), the global energy storage innovator, is delighted, further to its announcement on16 October 2025, to announce that the Tier One battery manufactu...

2025-10-21 14:00 2649

Xtep Launches Inaugural X-RUN CAMP for The Standard Chartered Heritage Marathon Hanoi in Vietnam

HANOI, Vietnam, Oct. 21, 2025 /PRNewswire/ -- As the strategic technology partner and exclusive gear sponsor of The Standard Chartered Heritage Marathon Hanoi, Xtep proudly supported the official launch of the SCHM X-RUN CAMP, held onOctober 19, 2025. Co-hosted by Xtep and Standard Chartered, the...

2025-10-21 11:27 3321

Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy

TAIPEI and SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system. DeepMind re...

2025-10-21 10:49 2941

Trinasolar and Mestron Energy Ink MOU to Strengthen Malaysia's National Energy Transition Roadmap Goals

Partnership to supply 50MW of Vertex N-type modules for renewable projects acrossMalaysia. SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- Trinasolar, a global leader in smart photovoltaic (PV) and energy storage solutions, has signed a memorandum of understanding (MoU) with Mestron Energy, a specialis...

2025-10-21 10:00 3536

Orbbec Captures 72% of Korea's Mobile Robot 3D Vision Market, New Report Shows

SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- Global market research firm Interact Analysis has released its3D Vision for South Korean Mobile Robots report, revealing that Orbbec hol...

2025-10-21 10:00 2092

SK Biopharmaceuticals Launches Joint Venture with Eurofarma for AI-based Epilepsy Management Platform

SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and co...

2025-10-21 09:20 1972

Investor Conference Call and Webcast on Shaakichiuwaanaan Project - Lithium-Only Feasibility Study Results

PMET Resources President and CEO Ken Brinsden to host an investor call MONTREAL and SYDNEY, Oct. 21, 2025 /PRNewswire/ -- PMET Resources Inc. (the "Company" or "PMET") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to advise that it will host a live investor teleconference and webca...

2025-10-21 05:45 1262

PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project

Unlocking Shaakichiuwaanaan's maiden Mineral Reserve and a key step towards final mine authorisation MONTREAL, Oct. 21, 2025 /PRNewswire/ -- October 21, 2025 – Sydney, Australia Highlights * Robust CV5 lithium-only Feasibility Study ("FS") completed on the Shaakichiuwaanaan Project (Project) ...

2025-10-21 05:45 1274

Eason Technology Limited Received NYSE American Non-Compliance Letter

HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason Technology" or the "Company") (NYSE:DXF

2025-10-21 04:59 3955

The Generation Essentials Group Reports on Half Year Performance with a ~160% Increase in Revenue

* TGE Achieved ~160% Increase in Revenue * Hospitality arm's revenue increased by over 60% * Total Net Income Surged over 70% to US$61.0 million (non-GAAP adjusted) * Total Assets amounted to US$1.25 billion (US$25.7/share) * Net asset value amounted to US$841 million (US$17.3/share) PARIS...

2025-10-20 20:45 2872

SM Investments certified as a Great Place to Work® in 2025

PASAY CITY, Philippines , Oct. 20, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments), the parent company of the SM group, has been certified as a Great Place to Work for 2025 by the global authority on workplace culture, Great Place to Work®. 

2025-10-20 20:45 1952

HanchorBio Showcases Pipeline Momentum with HCB101 and HCB301 Data Across Five Major Oncology Meetings in Q4 2025

Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stag...

2025-10-20 19:00 2471

IBM and Groq Partner to Accelerate Enterprise AI Deployment with Speed and Scale

Partnership aims to deliver faster agentic AI capabilities through IBM watsonx Orchestrate and Groq technology, enabling enterprise clients to take immediate action on complex workflows ARMONK, N.Y. and MOUNTAIN VIEW, Calif., Oct. 20, 2025 /PRNewswire/ -- IBM (NYSE:IBM

2025-10-20 18:09 1668

SKF at COP30: The world can't afford friction - it's time to scale what works

GOTHENBURG, Sweden, Oct. 20, 2025 /PRNewswire/ -- SKF will be attending COP30, held in Belém,Brazil in November 2025, to drive systemic change and progress through collaboration. A resilient industry demands open, systematic collaboration. SKF sees friction every day, in mindsets, metrics, and b...

2025-10-20 17:54 1448

Tiger Brokers (Hong Kong) Sponsors CFA Institute Research Challenge -- Hong Kong Local Final for the First Time, Introducing the "Star Presenter" Award

HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Tiger Brokers (Hong Kong) Global Limited ("Tiger Brokers (Hong Kong)") is proud to announce its inaugural sponsorship of the 2025–2026 CFA Institute Research Challenge — Hong Kong Local Final, underscoring the firm's commitment to talent development, profe...

2025-10-20 17:40 2427

The New England Journal of Medicine Publishes Results of Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan in Advanced EGFR-TKI-Resistant NSCLC

* After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to 0.62; two-sided P<0.0001). * OS was significantly longer with sac-TMT than with chemotherapy (H...

2025-10-20 17:06 1965

Global Chinese Wealth Manager Noah Holdings Hosts Inaugural N+ Art Club Exhibition in Shanghai: Hub: The Endless Exploration of Art

Extending Trust Between Cultures & Generations Through "Wisdom • Wealth • A Life of Warmth" SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-sto...

2025-10-20 16:53 4108

ESMO Congress 2025 Presidential Symposium Oral Presentation | Disitamab Vedotin Achieves Major Breakthrough as First-Line Treatment for Urothelial Carcinoma

BERLIN, Oct. 20, 2025 /PRNewswire/ -- At the 2025 European Society for Medical Oncology (ESMO) Congress, a Phase III clinical study on disitamab vedotin plus toripalimab versus chemotherapy as first-line treatment for HER2-expressing locally advanced or metastatic urothelial carcinoma (RC48-C016)...

2025-10-20 14:58 2319

HD Hyundai Vice Chairman Chung Kisun Promoted to Chairman

SEOUL, South Korea, Oct. 20, 2025 /PRNewswire/ -- HD Hyundai announced that Executive Vice ChairmanChung Kisun has been promoted to Chairman in its latest executive appointments. Chung Kisun, HD Hyundai Chairm...

2025-10-20 14:24 2425

3M at China Wind Power 2025: innovations empowering the future of green energy

BEIJING, Oct. 20, 2025 /PRNewswire/ -- On October 20, 2025, 3M, a global leader in diversified technology, made its appearance at the 2025 China Wind Power (CWP 2025). At this year's exhibition, 3M's booth theme was "With Wind as Wings, 3M Empowers a Green Future," focusing on showcasing innovativ...

2025-10-20 14:16 2082